AOD9604 5MG

AOD9604 (5MG)

AOD9604 is a peptide derived from the amino acid sequence of the human growth hormone-releasing hormone (GHRH) analog. Originally developed for potential therapeutic applications in the realm of endocrinology, it has been studied in preclinical research for its potential modulatory effects on growth hormone signaling pathways. This peptide is designated for research-use-only applications in a controlled laboratory setting.

Research Context

AOD9604 has been synthesized to explore its mechanisms of action within animal models. Early investigations have centered on its impact on the pituitary gland and subsequent regulation of growth hormone (GH) secretion. While not yet approved for clinical use, it remains a valuable tool for researchers studying peptide biology, hormonal regulation, and potential therapeutic strategies in animal models. Due to its specific sequence and structural attributes, AOD9604 can serve as a probe for studying GHRH receptor-mediated pathways.

Research Overview

AOD9604 was introduced as a synthetic alternative to endogenous GHRH analogs, offering a modified structure that may enhance stability and specificity in research settings. Preclinical studies have primarily focused on its ability to influence GH secretion in rodents and non-human primates, providing insights into hormonal feedback mechanisms. This peptide is often used in conjunction with other research tools, such as GHRH antagonists or receptor-specific antibodies, to elucidate its role in modulating growth and metabolism.

Key Research Focus Areas

• Growth Hormone Secretion: Investigation into its effects on pituitary GH release, particularly in comparison to native GHRH analogs.
• Receptor Binding Studies: Assessment of AOD9604’s affinity for the GHRH receptor, including its potential to distinguish between different receptor subtypes.
• Metabolic and Anabolic Effects: Preliminary evaluations of its impact on growth, tissue regeneration, and metabolic processes in animal models.
• Cross-Species Comparisons: Analysis of its activity in non-human primates and rodents to identify conservation or divergence of GHRH signaling pathways.
• Stability and Bioavailability: Characterization of its degradation profile and pharmacokinetic properties in research contexts.

This peptide is intended solely for academic or industrial research applications under the supervision of qualified professionals. It is not approved for human or veterinary use.

Compliance Notice

For research use only. Not for human or animal consumption. Unauthorized use is strictly prohibited. Always follow institutional guidelines for handling and storage of research materials.